SHOX2 and lung cancer: Furthermore, SHOX2 DNA methylation is a validated biomarker for detecting lung cancer in the cellular fraction of bronchial aspirates [12], [13] and pleural effusions [14], [15] as well as in EBUS-TBNA (endobronchial ultrasound with transbronchial needle aspiration) specimens [16].